Literature DB >> 9812081

Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope.

C Zeng1, Z Zhu, G Liu, W Hu, X Wang, C Yang, H Wang, D He, J Tan.   

Abstract

BACKGROUND: The purpose of this study was to study the effect of enalapril on neurally mediated syncope (NMS). Several agents (except for angiotensin-converting enzyme [ACE] inhibitors) have been used to treat patients with NMS. It is unknown whether ACE inhibitors have beneficial effects on NMS. METHODS AND
RESULTS: Thirty subjects who had reproducible NMS induced with head-up tilt table test (HUT) were randomly assigned and divided in double-blind fashion into placebo and enalapril (an ACE inhibitor) groups. Hemodynamics and plasma catecholamine concentrations were studied. Before administration of enalapril, syncope induced by HUT was associated with vigorous hypotension and bradycardia. Plasma catecholamine concentrations were significantly elevated during NMS compared with the supine position before tilt. Oral enalapril rather than placebo produced a marked reduction in diastolic blood pressure during supine positioning before tilt. Administration of enalapril prevented HUT-induced NMS and increase of plasma catecholamine concentrations in all patients examined. Conversely, placebo had no effect in the majority of patients with NMS (12 of 15 subjects). Follow-up data showed that NMS disappeared in 14 (93%) of 15 patients treated with enalapril.
CONCLUSIONS: This study demonstrates that ACE inhibitors may efficiently prevent NMS, presumably through inhibition of sympathetic system activation and peripheral hypotensive effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9812081     DOI: 10.1016/s0002-8703(98)70131-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

Review 2.  Strategy for the management of vasovagal syncope.

Authors:  Daniel M Bloomfield
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Poor diagnostic performance of tilt testing in hypertensive patients with unexplained syncope.

Authors:  A Ungar; M Rafanelli; T Cellai; A Ceccofiglio; A Del Rosso; C Mussi; N Marchionni
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

4.  Syncope.

Authors:  Pamela Nerheim; Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08

5.  Segmentation and quantification of COVID-19 infections in CT using pulmonary vessels extraction and deep learning.

Authors:  João O B Diniz; Darlan B P Quintanilha; Antonino C Santos Neto; Giovanni L F da Silva; Jonnison L Ferreira; Stelmo M B Netto; José D L Araújo; Luana B Da Cruz; Thamila F B Silva; Caio M da S Martins; Marcos M Ferreira; Venicius G Rego; José M C Boaro; Carolina L S Cipriano; Aristófanes C Silva; Anselmo C de Paiva; Geraldo Braz Junior; João D S de Almeida; Rodolfo A Nunes; Roberto Mogami; M Gattass
Journal:  Multimed Tools Appl       Date:  2021-06-24       Impact factor: 2.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.